March 12, 2018
Sarepta Therapeutics Plans to Submit DMD Drug Golodirsen for FDA Approval by Year End
Read More
September 19, 2016
Duchenne Community Rejoices over FDA Approval of Eteplirsen!
Read More
July 17, 2015
Sarepta Planning to Dominate Duchennes in Rare Disease Race With BioMarin
Read More
July 12, 2015
Mark Chapman Shares an Investor’s Guide for The Race To Cure Duchenne Muscular Dystrophy
Read More
X